Patent granted for toxoplasmosis research

  • April 29, 2014
Patent granted for toxoplasmosis research

Bo Shiun Lai and his research colleagues have been granted a patent by the US authorities to develop a treatement for toxoplasmosis.

A Gates Cambridge Scholar and his team have been granted a patent by the US authorities to develop a treatement for toxoplasmosis.

Bo Shiun Lai [2013] and colleagues submitted a patent application around a year and a half ago when Bo Shiun was still doing his undergraduate degree at the Univesity of Chicago and have just been awarded a US patent. He is continuing his research at the University of Cambridge, where he is doing a PhD in Pathology.

Toxoplasmosis is a parasite which is hosted by two billion people worldwide, mostly without any visible symptoms. However, if their immune system is suppressed, for instance, if they are newborn or have HIV, it can cause serious problems. In newborns it can cause ocular impairment or brain defects and brain inflammation caused by toxoplasmosis is a major cause of death in people with HIV. It is relatively rare among newborns and has been considered a neglected disease, but since 9/11, it has been classified as a bioterror agent by the US National Institute of Allergy and Infectious Diseases (NIAID) which led to increased interest until the financial meltdown.

Toxoplasmosis takes two forms: active and dormant. When it is dormant the parasite wraps itself in a thick layer of lipid which makes it impervious to all drug treatment and impossible to eradicate. Bo Shiun’s research into toxoplasmosis focuses on two main challenges: how to deliver drugs across the lipid barrier and what specific molecular pathways to inhibit. As toxoplasmosis mainly resides in the eyes and brain, treatment has to cross the ocular membrane or enter the brain.

His work prior to arriving at Cambridge in 2013 was focused on the first challenge, attempting to create a molecule that could have an inhibitory effect on the parasite and deliver medication across multiple membranes. At Cambridge, he has been targeting the second challenge – how to switch the parasite from dormant to active mode, making it susceptible to existing treatment, or shut off essential pathways, killing the parasite effectively.

He says: “This approach is a breakthrough because it allows us to deliver drugs across numerous layers of obstacles, arrive at the intended target (ideally essential for parasite survival or replication), and abrogate parasite growth. The patent is promising for delivering inhibitory molecules into both active and dormant parasites.”

The researchers found that their original model had a small therapeutic range in which it could be both effective and non toxic. They believe the toxicity originates from the transductive peptides which help deliver the drugs across the lipid barrier to the parasite and have been trying to reduce it. So far they have expanded the therapeutic range by about four times. Bo Shiun says: “This means we can increase the dosage dramatically without observable toxicity.”

Bo Shiun’s work has seen him nominated for the Cozzarelli Prize, a national award for scientific excellence in a particular scientific discipline and three of his articles were accepted for publication in peer review journals before he finished his undergraduate degree.

Latest News

Provost wins top Royal Society award

Gates Cambridge Provost Professor Barry Everitt has been selected for the Royal Society’s premier award in the biological sciences. Professor Barry Everitt FMedSci FRS has been awarded the Croonian Medal and Lecture 2021 for his research on the application of his findings on brain mechanisms of motivation to important societal issues, such as drug addiction. […]

Addressing energy injustice in the Global South

A new framework which uses artificial intelligence to analyse textual data on energy use and behaviour could help policymakers develop a deeper understanding of energy injustices in the Global South. The study, Grounded reality meets machine learning: A deep-narrative analysis framework for energy policy research, was led by Gates Cambridge Scholar Ramit Debnath [2018] and is published in the journal Energy Research […]

Scholar wins top German prize for PhD thesis

A Gates Cambridge Scholar has won a prestigious international award for her PhD dissertation on the relationship between offshore finance and state power. Dr Andrea Binder was named winner of the Körber Foundation’s German Dissertation Award 2020 for social sciences. The prize, one of the most highly endowed for young researchers from Germany, honours excellent PhD research which […]

Developing a farm for impact model

Shadrack Frimpong has not yet started his PhD, but already his and his team’s work has earned him awards from the Queen, the Clinton Foundation and the Muhammad Ali Foundation. The awards are for their outstanding work in creating a potential new development model for rural crop-growing communities starting from Shadrack’s own village in Ghana. […]